Presenilin 1 Polyclonal Antibody

Alzheimer's disease (AD) patients with an inherited form of the disease carry mutations in the presenilin proteins (PSEN1; PSEN2) or in the amyloid precursor protein (APP). These disease-linked mutations result in increased production of the longer form of amyloid-beta (main component of amyloid deposits found in AD brains). Presenilins are postulated to regulate APP processing through their effects on gamma-secretase, an enzyme that cleaves APP. Also, it is thought that the presenilins are involved in the cleavage of the Notch receptor, such that they either directly regulate gamma-secretase activity or themselves are protease enzymes. Several alternatively spliced transcript variants encoding different isoforms have been identified for this gene, the full-length nature of only some have been determined.

The Presenilin 1 Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and analysis of Presenilin 1 protein in various biological samples. This antibody has been meticulously developed using advanced immunization techniques, ensuring its exceptional affinity and selectivity towards Presenilin 1.

Presenilin 1 is a crucial component of the γ-secretase complex, which plays a pivotal role in the proteolytic processing of amyloid precursor protein (APP) and the generation of amyloid beta (Aβ) peptides. Dysregulation of Presenilin 1 has been implicated in the pathogenesis of Alzheimer's disease, making it an important target for research and therapeutic interventions.

The Presenilin 1 Polyclonal Antibody exhibits outstanding performance in various applications, including Western blotting, immunohistochemistry, and immunofluorescence. It has been rigorously validated to ensure reliable and reproducible results, enabling accurate quantification and localization of Presenilin 1 in diverse experimental settings.

This antibody is produced using high-quality materials and undergoes stringent quality control measures to guarantee batch-to-batch consistency and optimal performance. It is supplied as a liquid formulation, ready for immediate use, and is compatible with a wide range of experimental conditions and sample types.

In summary, the Presenilin 1 Polyclonal Antibody is an indispensable tool for researchers investigating the role of Presenilin 1 in neurodegenerative diseases, particularly Alzheimer's disease. Its exceptional specificity, sensitivity, and versatility make it an invaluable asset in elucidating the molecular mechanisms underlying Presenilin 1 function and its potential as a therapeutic target.